Seres Therapeutics Inc MCRB:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:07 PM EDT
23.25UNCH (UNCH)
Volume
244,250
Close
23.25quote price arrow down-0.08 (-0.34%)
Volume
735,182
52 week range
3.67 - 38.50

...

Loading . . .
  • Open23.45
  • Day High24.00
  • Day Low22.60
  • Prev Close23.33
  • 52 Week High38.50
  • 52 Week High Date11/18/20
  • 52 Week Low3.67
  • 52 Week Low Date07/31/20

Key Stats

  • Market Cap2.132B
  • Shares Out91.68M
  • 10 Day Average Volume0.84M
  • Dividend-
  • Dividend Yield-
  • Beta3.91
  • YTD % Change-5.1

KEY STATS

  • Open23.45
  • Day High24.00
  • Day Low22.60
  • Prev Close23.33
  • 52 Week High38.50
  • 52 Week High Date11/18/20
  • 52 Week Low3.67
  • 52 Week Low Date07/31/20
  • Market Cap2.132B
  • Shares Out91.68M
  • 10 Day Average Volume0.84M
  • Dividend-
  • Dividend Yield-
  • Beta3.91
  • YTD % Change-5.1

RATIOS/PROFITABILITY

  • EPS (TTM)-1.23
  • P/E (TTM)-18.87
  • Fwd P/E (NTM)-13.92
  • EBITDA (MRQ)-97.512M
  • ROE (MRQ)-255.22%
  • Revenue (MRQ)30.74M
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-340.59%
  • Debt To Equity (MRQ)17.54%

EVENTS

  • Earnings Date07/26/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Seres Therapeutics Inc

There is no recent news for this security.

Profile

MORE
Seres Therapeutics, Inc. is a microbiome therapeutics platform company. The Company is engaged in developing a class of biological drugs, which is referred as Ecobiotic microbiome therapeutics. The Company's drugs are designed to restore health by repairing the function of a dysbiotic microbiome. The Company is focused on implementing its microbiome therapeutics platform to develop Ecobiotic microbiome therapeutics that treats dysbiosis in the colonic microbiome. SER-109 is...
Stephen Berenson
Chairman
Eric Shaff
President
David Arkowitz
Chief Financial Officer
David Ege Ph.D.
Executive Vice President
John Aunins Ph.D.
Executive Vice President
Address
200 Sidney St
Cambridge, MA
02139-4218
United States

Top Peers

SYMBOLLASTCHG%CHG
PTGX
Protagonist Therapeutics Inc
43.27-0.13-0.30%
RVNC
Revance Therapeutics Inc
31.30-0.03-0.10%
ZNTL
Zentalis Pharmaceuticals Inc
52.33+0.20+0.38%
MYOV
Myovant Sciences Ltd
21.94+0.33+1.53%
ALEC
Alector Inc
20.86-0.44-2.07%